208 related articles for article (PubMed ID: 31949481)
1. FOXM1 functions collaboratively with PLAU to promote gastric cancer progression.
Ai C; Zhang J; Lian S; Ma J; Győrffy B; Qian Z; Han Y; Feng Q
J Cancer; 2020; 11(4):788-794. PubMed ID: 31949481
[No Abstract] [Full Text] [Related]
2. Effect of urokinase-type plasminogen activator combined with clinical stage and Barcelona Clinic Liver Cancer stage on the prognosis of patients with hepatocellular carcinoma.
Wu J; Sun M; Li Z; Shen Y; Wu Y; Zhang H; Xu Z; Gao Q
J Gastrointest Oncol; 2023 Jun; 14(3):1434-1450. PubMed ID: 37435232
[TBL] [Abstract][Full Text] [Related]
3. CTSK and PLAU as Prognostic Biomarker and Related to Immune Infiltration in Pancreatic Cancer: Evidence from Bioinformatics Analysis and qPCR.
Ding Y; Li Z; Wang H; Wang Q; Jiang H; Yu Z; Xu M
Int J Genomics; 2023; 2023():3914687. PubMed ID: 38077303
[TBL] [Abstract][Full Text] [Related]
4. Hypomethylation and downregulation of miR-23b-3p are associated with upregulated PLAU: a diagnostic and prognostic biomarker in head and neck squamous cell carcinoma.
Huo Z; Li X; Zhou J; Fan Y; Wang Z; Zhang Z
Cancer Cell Int; 2021 Oct; 21(1):564. PubMed ID: 34702271
[TBL] [Abstract][Full Text] [Related]
5. Multiplexed immunofluorescence analysis of CAF-markers, EZH2 and FOXM1 in gastric tissue: associations with clinicopathological parameters and clinical outcomes.
Sun H; Wang X; Zhang X; Wang X; Tan C; Weng W; Zhang M; Ni S; Wang L; Huang D; Xu M; Sheng W
BMC Cancer; 2022 Nov; 22(1):1188. PubMed ID: 36401232
[TBL] [Abstract][Full Text] [Related]
6. Identification and verification of the prognostic value of the glutathione S-transferase Mu genes in gastric cancer.
Chen Y; Li B; Wang J; Liu J; Wang Z; Mao Y; Liu S; Liao X; Chen J
Oncol Lett; 2020 Oct; 20(4):100. PubMed ID: 32831919
[TBL] [Abstract][Full Text] [Related]
7. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Significance and Gene Co-Expression Network of
Li J; Fan H; Zhou X; Xiang Y; Liu Y
Front Oncol; 2021; 11():602321. PubMed ID: 35087738
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and prognostic significance of FoxM1 in gastric cancer: A meta-analysis.
Jiang D; Jiang L; Liu B; Huang H; Li W; Zhang T; Zu G; Zhang X
Int J Surg; 2017 Dec; 48():38-44. PubMed ID: 29017864
[TBL] [Abstract][Full Text] [Related]
10. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
[TBL] [Abstract][Full Text] [Related]
11. LUM Expression and Its Prognostic Significance in Gastric Cancer.
Chen X; Li X; Hu X; Jiang F; Shen Y; Xu R; Wu L; Wei P; Shen X
Front Oncol; 2020; 10():605. PubMed ID: 32500021
[No Abstract] [Full Text] [Related]
12. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116
[TBL] [Abstract][Full Text] [Related]
13. Identification of SERPINE1, PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysis.
Yang K; Zhang S; Zhang D; Tao Q; Zhang T; Liu G; Liu X; Zhao T
Int J Clin Oncol; 2019 Sep; 24(9):1030-1041. PubMed ID: 30937621
[TBL] [Abstract][Full Text] [Related]
14. Expression of CDCA8 correlates closely with FOXM1 in breast cancer: public microarray data analysis and immunohistochemical study.
Jiao DC; Lu ZD; Qiao JH; Yan M; Cui SD; Liu ZZ
Neoplasma; 2015; 62(3):464-9. PubMed ID: 25866227
[TBL] [Abstract][Full Text] [Related]
15. Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients.
Liang J; Liu Z; Wei X; Zhou L; Tang Y; Zhou C; Wu K; Zhang F; Zhang F; Lu Y; Zhu Y
BMC Cancer; 2019 Nov; 19(1):1165. PubMed ID: 31783819
[TBL] [Abstract][Full Text] [Related]
16. Methylation-Driven Gene PLAU as a Potential Prognostic Marker for Differential Thyroid Carcinoma.
Wu M; Wei B; Duan SL; Liu M; Ou-Yang DJ; Huang P; Chang S
Front Cell Dev Biol; 2022; 10():819484. PubMed ID: 35141223
[No Abstract] [Full Text] [Related]
17. Knockdown of the FoxM1 enhances the sensitivity of gastric cancer cells to cisplatin by targeting Mcl-1.
Li X; Liang J; Liu YX; Wang Y; Yang XH; Bao-Hongluan ; Zhang GL; Du J; Wu XH
Pharmazie; 2016 Jun; 71(6):345-8. PubMed ID: 27455555
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of DGKI in Gastric Cancer Predicts Poor Prognosis.
Huang C; Zhao J; Luo C; Zhu Z
Front Med (Lausanne); 2020; 7():320. PubMed ID: 32733904
[No Abstract] [Full Text] [Related]
19. FOXM1-LDHA signaling promoted gastric cancer glycolytic phenotype and progression.
Jiang W; Zhou F; Li N; Li Q; Wang L
Int J Clin Exp Pathol; 2015; 8(6):6756-63. PubMed ID: 26261559
[TBL] [Abstract][Full Text] [Related]
20. Expression Status And Prognostic Value Of M6A-associated Genes in Gastric Cancer.
Guan K; Liu X; Li J; Ding Y; Li J; Cui G; Cui X; Sun R
J Cancer; 2020; 11(10):3027-3040. PubMed ID: 32226518
[No Abstract] [Full Text] [Related]
[Next] [New Search]